Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
5.64
-0.02 (-0.35%)
Aug 12, 2026, 11:29 AM CST
SHA:600223 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,675 | 3,651 | 3,983 | 4,579 | 12,951 | 12,363 |
Revenue Growth | -7.38% | -8.33% | -13.02% | -64.65% | 4.76% | -9.20% |
Gross Profit Gross Profit Growth | 1,974 | 1,919 | 2,093 | 2,121 | 2,926 | 2,980 |
Operating Income Operating Income Growth | 146.87 | 173.29 | 214.71 | 227.71 | 575.66 | 636.91 |
Net Income Net Income Growth | 168.94 | 187.75 | 243.53 | 303.39 | 45.46 | 361.9 |
Earnings Per Share EPS Growth | 0.16 | 0.18 | 0.24 | 0.30 | 0.04 | 0.35 |
EPS Growth | -30.42% | -25.00% | -20.00% | 650.00% | -88.57% | -44.44% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical and Chemical Industry Pharmaceutical and Chemical Industry Growth | 3,080 |
Property Management and Other Industries Property Management and Other Industries Growth | 579.93 |
Offset of Division Offset of Division Growth | -8.58 |
Total Total Growth | 3,651 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,873 | 2,895 | 2,948 | 1,734 | 4,318 | 5,139 |
Total Debt Total Debt Growth | 175.8 | 136.94 | 285.92 | 2,182 | 7,735 | 9,287 |
Net Cash (Debt) Net Cash Growth | 2,697 | 2,758 | 2,662 | -448.16 | -3,417 | -4,149 |
Net Cash Growth | 7.65% | 3.62% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2.56 | 2.64 | 2.62 | -0.44 | -3.01 | -4.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 363.94 | 276.22 | 228.65 | 474.15 | 998.1 | 6,848 |
Capital Expenditures CapEx Growth | -95.52 | -110.42 | -157.22 | -211.37 | -166.11 | -281.53 |
Free Cash Flow Free Cash Flow Growth | 268.42 | 165.8 | 71.44 | 262.79 | 831.98 | 6,567 |
Free Cash Flow Growth | - | 132.10% | -72.82% | -68.41% | -87.33% | 53.04% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.71% | 52.57% | 52.56% | 46.33% | 22.59% | 24.10% |
Operating Margin | 4.00% | 4.75% | 5.39% | 4.97% | 4.45% | 5.15% |
Pretax Margin | 7.06% | 7.80% | 8.70% | 9.02% | 2.02% | 5.21% |
Profit Margin | 4.60% | 5.14% | 6.12% | 6.63% | 0.35% | 2.93% |
FCF Margin | 7.30% | 4.54% | 1.79% | 5.74% | 6.42% | 53.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.057 | 0.057 | 0.110 | 0.100 | 0.110 | 0.110 |
Dividend Per Share Growth | -48.18% | -48.18% | 10.00% | -9.09% | 0% | -45.00% |
Dividend Yield | 1.00% | 0.78% | 1.48% | 1.08% | 1.08% | 0.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.36 | 39.85 | 31.56 | 32.27 | 236.84 | 36.95 |
Forward PE | 23.58 | 24.71 | 21.34 | 21.45 | 24.32 | 13.45 |
P/FCF Ratio | 21.44 | 45.13 | 107.58 | 37.25 | 12.94 | 2.04 |
PS Ratio | 1.57 | 2.05 | 1.93 | 2.14 | 0.83 | 1.08 |